The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves (Q45746012)

15 December 2017

title

The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves (English)

1 reference

15 December 2017

main subject

experimental infection

1 reference

West K

1

1 reference

15 December 2017

Petrie L

2

1 reference

15 December 2017

Konoby C

3

1 reference

15 December 2017

Haines DM

4

1 reference

15 December 2017

Cortese V

5

1 reference

15 December 2017

Ellis JA

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

18

1 reference

15 December 2017

issue

9-10

1 reference

15 December 2017

page(s)

907-919

1 reference

15 December 2017

Respiratory syncytial virus infections in human beings and in cattle

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Immunity to human and bovine respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Bovine respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Double blind field evaluation of a trivalent vaccine against respiratory disease in veal calves

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

A bovine respiratory virus vaccination trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Prevention of bovine respiratory syncytial virus infection and clinical disease by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Lymphocyte transformation response of calves to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

The Role of Passive Immunity in Bovine Respiratory Syncytial Virus-Infected Calves

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Cardiac catheterization of unanesthetized large domestic animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

The stabilization and purification of respiratory syncytial virus using MgSO4.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Bovine respiratory syncytial virus-specific immune responses in cattle following immunization with modified-live and inactivated vaccines. Analysis of proliferation and secretion of lymphokines by leukocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

The gamma-interferon assay for diagnosis of bovine tuberculosis in cattle: conditions affecting the production of gamma-interferon in whole blood culture

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Differential and strain-specific triggering of bovine alveolar macrophage effector functions by mycoplasmas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Effects of age, environmental temperature and relative humidity on the colonization of the nose and trachea of calves by Mycoplasma spp

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Acute fatal pneumonia in calves due to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Cellular and humoral immunity in recurrent respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Cell-mediated cytotoxicity of bovine mononuclear cells to IBRV-infected cells: dependence on Sephadex G-10 adherent cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Unilateral nasal infection of cotton rats with respiratory syncytial virus allows assessment of local and systemic immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Epidemiological study of bovine respiratory syncytial virus infections in calves: influence of maternal antibodies on the outcome of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

Human and bovine respiratory syncytial virus: immunopathologic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900324-2

7 January 2021

10.1016/S0264-410X(99)00324-2

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10580205

1 reference

15 December 2017